Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Peyronie's Disease, Erectile Dysfunction, and Interstitial Cystitis
Status: Recruiting
Location: See location...
Intervention Type: Biological
Study Type: Interventional
Study Phase: Phase 1
SUMMARY
This trial will study the safety and efficacy of intravenous and intracavernosal or interstitial delivery of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Peyronie's disease, erectile dysfunction , and Interstitial Cystitis
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Diagnosis of Peyronie's Disease, erectile dysfunction, or Interstitial Cystitis
• Understanding and willingness to sign a written informed consent document
Locations
Other Locations
Antigua and Barbuda
Medical Surgical Associates Center
RECRUITING
St John's
Time Frame
Start Date: 2021-09-12
Estimated Completion Date: 2025-12
Participants
Target number of participants: 20
Treatments
Experimental: Treatment Group (AlloRx)
intravenous and intracavernosal or interstitial delivery (total dose of 100 million cells)
Related Therapeutic Areas
Sponsors
Leads: The Foundation for Orthopaedics and Regenerative Medicine